|
WO2021009761A1
|
|
Combination therapy for the treatment of cancer
|
|
WO2020148745A1
|
|
Specific combination therapy for treatment of pancreatic cancer
|
|
WO2020079692A1
|
|
Treatment of metastatic pancreatic adenocarcinoma
|
|
WO2020148744A1
|
|
Combination therapy for treatment of pancreatic cancer
|
|
WO2020065647A1
|
|
Methods of selecting treatment for cxcr4-associated cancer
|
|
EP3801614A1
|
|
Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
|
US2020282009A1
|
|
Methods of treating diseases associated with vascular smooth muscle cell proliferation
|
|
CA3014530A1
|
|
Methods of treating acute myeloid leukemia
|
|
AU2016291817A1
|
|
Compositions and methods for treating cancer
|
|
WO2015015489A1
|
|
Antibody for treating diabetes and autoimmune diseases
|
|
CA2906314A1
|
|
Methods of treating myeloid leukemia
|
|
WO2012137164A1
|
|
Antimicrobial compositions, antibiofilm compositions and uses thereof
|
|
CA2782514A1
|
|
Methods of improving cognitive functions
|
|
EP2136783A2
|
|
A method of promoting muscle tissue repair
|
